Also known as: Victoza, Saxenda
FDA-approved GLP-1 receptor agonist for type 2 diabetes and obesity. Extensive clinical trial evidence.
📖 Read the full Liraglutide research overview →
Evidence Tier: Tier 1 — Approved Drug · Peptidings Verdict: Strong Foundation